Nexien Biopharma Stock Price on April 26, 2024
| NXEN Stock | USD 0.01 0.01 25.00% |
If you're considering investing in Nexien Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Nexien Biopharma stands at 0.01, as last reported on the 23rd of November, with the highest price reaching 0.01 and the lowest price hitting 0.01 during the day. Nexien Biopharma is out of control given 3 months investment horizon. Nexien Biopharma has Sharpe Ratio of 0.13, which conveys that the firm had a 0.13% return per unit of risk over the last 3 months. We were able to analyze and collect data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 4.63% are justified by taking the suggested risk. Use Nexien Biopharma Mean Deviation of 19.54, downside deviation of 35.62, and Risk Adjusted Performance of 0.1144 to evaluate company specific risk that cannot be diversified away.
Nexien Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Nexien |
Sharpe Ratio = 0.1333
| Best Portfolio | Best Equity | NXEN | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 34.74 actual daily | 96 96% of assets are less volatile |
Expected Return
| 4.63 actual daily | 92 92% of assets have lower returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average Nexien Biopharma is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nexien Biopharma by adding it to a well-diversified portfolio.
Nexien Biopharma Valuation on April 26, 2024
It is possible to determine the worth of Nexien Biopharma on a given historical date. On April 26, 2024 Nexien was worth 0.017 at the beginning of the trading date compared to the closed value of 0.017. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Nexien Biopharma pink sheet. Still, in general, we apply an absolute valuation method to find Nexien Biopharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Nexien Biopharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Nexien Biopharma's related companies.
| Open | High | Low | Close | Volume | |
| 0.02 | 0.02 | 0.02 | 0.02 | 1,200 | |
04/26/2024 | 0.02 | 0.02 | 0.02 | 0.02 | 4,000 |
| 0.02 | 0.02 | 0.02 | 0.02 | 2,800 |
| Backtest Nexien Biopharma | | | Nexien Biopharma History | | | Nexien Biopharma Valuation | Previous | Next |
Nexien Biopharma Trading Date Momentum on April 26, 2024
| On April 29 2024 Nexien Biopharma was traded for 0.02 at the closing time. The top price for the day was 0.02 and the lowest listed price was 0.02 . The trading volume for the day was 2.8 K. The trading history from April 29, 2024 did not cause price change. The trading delta at closing time against the current closing price is 23.53% . |
Nexien Biopharma Fundamentals Correlations and Trends
By evaluating Nexien Biopharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Nexien Biopharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Nexien financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Nexien Biopharma Pink Sheet history
Nexien Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Nexien is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Nexien Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Nexien Biopharma stock prices may prove useful in developing a viable investing in Nexien Biopharma
Nexien BioPharma, Inc. operates as a pharmaceutical company. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien Biopharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
Nexien Biopharma Pink Sheet Technical Analysis
Nexien Biopharma technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Nexien Biopharma Period Price Range
Low | November 23, 2024
| High |
0.00 | 0.00 |
Nexien Biopharma cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Nexien Biopharma November 23, 2024 Market Strength
Market strength indicators help investors to evaluate how Nexien Biopharma pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Nexien Biopharma shares will generate the highest return on investment. By undertsting and applying Nexien Biopharma pink sheet market strength indicators, traders can identify Nexien Biopharma entry and exit signals to maximize returns
Nexien Biopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Nexien Biopharma's price direction in advance. Along with the technical and fundamental analysis of Nexien Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Nexien to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1144 | |||
| Jensen Alpha | 4.28 | |||
| Total Risk Alpha | (0.73) | |||
| Sortino Ratio | 0.1274 | |||
| Treynor Ratio | 1.46 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Other Information on Investing in Nexien Pink Sheet
Nexien Biopharma financial ratios help investors to determine whether Nexien Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nexien with respect to the benefits of owning Nexien Biopharma security.